Sellas Stock 346% Year Near Final REGAL Deaths Ahead
Sellas Life Sciences has surged 346% over the past year as its REGAL trial for a WT1-targeting cancer vaccine moves t...
Looking to grow your wealth effectively? Explore valuable wealth accumulation tips for success and enhance your financial journey.
8,615 articlesSellas Life Sciences has surged 346% over the past year as its REGAL trial for a WT1-targeting cancer vaccine moves t...
Palo Alto Networks has accelerated into platform play by acquiring three firms over the past year. This article break...
Tim Cook used the China Development Forum to stress collaboration with Chinese partners as Beijing intensifies policy...
Alibaba is reshaping itself from a pure e-commerce giant into a cloud and AI contender. With profits under pressure a...
A KRW-backed stablecoin and offshore perpetual futures contract launch in April 2026, signaling Wall Street’s push to...
Intel kicked off a high-volume enterprise processor launch, lifting the stock as investors weigh the company’s path b...
Arm is venturing into in house silicon for AI workloads, a bold move that could redefine its growth path. This articl...
AST SpaceMobile has captured attention with a surge tied to high-profile deals. This guide breaks down what the stock...
A new survey of 150 enterprise leaders shows procurement friction is slowing AI deals as buyers struggle to map budge...
The VanEck PPH ETF faces two key risks in 2026: heavy concentration in Eli Lilly and shifting U.S. drug pricing polic...
CME is moving to introduce Bitcoin volatility futures that track market expectations of price swings, separate from B...
As of May 7, 2026, Trump’s drug-pricing drive shows a mixed outcome: some medicines price cuts, but many others highe...